United States · FDA National Drug Code directory
levocetirizine dihydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-680_1a939b38-64a2-4238-816d-4c01075e5cbe
- Product NDC
- 45802-680
- Form
- SOLUTION
- Composition / generic term
- Levocetirizine dihydrochloride
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111107
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 148 mL in 1 BOTTLE (45802-680-28) · 45802-680-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →